Market Overview

Neogenomics (NASDAQ: NEO)

45.50 +0.73 (1.63%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/20/20SVB LeerinkMaintainsOutperform50.0
10/28/20Raymond JamesMaintainsOutperform48.0
10/28/20BenchmarkMaintainsBuy48.0
10/28/20NeedhamMaintainsBuy46.0
10/28/20SVB LeerinkMaintainsOutperform47.0
10/26/20CIBCUpgradesOutperformer14.5
9/09/20Morgan StanleyInitiates Coverage OnOverweight46.0
8/28/20GuggenheimInitiates Coverage OnBuy46.0
7/29/20Raymond JamesMaintainsOutperform40.0
7/29/20BenchmarkMaintainsBuy40.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter